Cerdá-Reverter et al., 2011 - Google Patents
Fish melanocortin systemCerdá-Reverter et al., 2011
View PDF- Document ID
- 17727707464739614596
- Author
- Cerdá-Reverter J
- Agulleiro M
- Guillot R
- Sánchez E
- Ceinos R
- Rotllant J
- Publication year
- Publication venue
- European journal of pharmacology
External Links
Snippet
Melanocortin signalling is mediated by binding to a family of G protein-coupled receptors that positively couple to adenylyl cyclase. Tetrapod species have five melanocortin (MC1– MC5) receptors. The number of receptors varies in fish, zebrafish, for example, having six …
- 239000002865 melanocortin 0 title abstract description 145
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cerdá-Reverter et al. | Fish melanocortin system | |
| Polidori et al. | The hyperphagic effect of nociceptin/orphanin FQ in rats. | |
| Cerdá-Reverter et al. | The central melanocortin system regulates food intake in goldfish | |
| Wettstein et al. | Central nervous system pharmacology of neuropeptide Y | |
| Nakatsuji et al. | Crustacean molt-inhibiting hormone: structure, function, and cellular mode of action | |
| Dores et al. | 60 Years of POMC: melanocortin receptors: evolution of ligand selectivity for melanocortin peptides | |
| Olias et al. | Regulation and function of somatostatin receptors | |
| Haskell-Luevano et al. | Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor | |
| Pierantoni et al. | Evolutionary aspects of cellular communication in the vertebrate hypothalamo–hypophysio–gonadal axis | |
| Tao | Mutations in melanocortin‐4 receptor and human obesity | |
| Yang et al. | Modulatory role of neuropeptide FF system in nociception and opiate analgesia | |
| Metz et al. | Molecular biology and physiology of the melanocortin system in fish: a review | |
| Agulleiro et al. | Characterization, tissue distribution and regulation by fasting of the agouti family of peptides in the sea bass (Dicentrarchus labrax) | |
| Mellström et al. | Transcriptional response to cAMP in brain: specific distribution and induction of CREM antagonists | |
| Berruien et al. | Emerging roles of melanocortin receptor accessory proteins (MRAP and MRAP2) in physiology and pathophysiology | |
| US9074012B2 (en) | Molecular control of brown fat differentiation and energy expenditure | |
| JP2003335702A (en) | Method and reagent for finding and using mammalian melanocortin receptor agonist and antagonist for adjusting ingestion behavior in animal | |
| Guillot et al. | Behind melanocortin antagonist overexpression in the zebrafish brain: a behavioral and transcriptomic approach | |
| Malendowicz et al. | Neuromedins NMU and NMS: an updated overview of their functions | |
| Yang et al. | Characterization of channel catfish (Ictalurus punctatus) melanocortin-3 receptor reveals a potential network in regulation of energy homeostasis | |
| Harrold et al. | β-MSH: a functional ligand that regulated energy homeostasis via hypothalamic MC4-R? | |
| Moon et al. | Molecular cloning of the bullfrog kisspeptin receptor GPR54 with high sensitivity to Xenopus kisspeptin | |
| Zhang et al. | The Asp298Asn polymorphism of melanocortin‐4 receptor (MC4R) in pigs: evidence for its potential effects on MC4R constitutive activity and cell surface expression | |
| Eberle | Proopiomelanocortin and the melanocortin peptides | |
| Doering et al. | Discovery of mixed pharmacology melanocortin-3 agonists and melanocortin-4 receptor tetrapeptide antagonist compounds (TACOs) based on the sequence Ac-Xaa1-Arg-(pI) DPhe-Xaa4-NH2 |